§ 13F · FUND PROFILE
Bain Capital Life Sciences Investors, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $1.5B (13F)Positions · 21Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$61M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | HTFL | HEARTFLOW INC | 10.45M | $254M | 22.9% | −16% |
| 2 | NAMS | NEWAMSTERDAM PHARMA COMPANY | 7.31M | $234M | 21.1% | ±0% |
| 3 | OLMA | OLEMA PHARMACEUTICALS INC | 7.47M | $111M | 10.0% | −12% |
| 4 | SVRA | SAVARA INC | 17.60M | $96M | 8.7% | ±0% |
| 5 | PHVS | PHARVARIS N V | 2.68M | $76M | 6.8% | −5% |
| 6 | SLDB | SOLID BIOSCIENCES INC | 9.81M | $71M | 6.4% | +24% |
| 7 | XFOR | X4 PHARMACEUTICALS INC | 7.97M | $33M | 3.0% | ±0% |
| 8 | DNTH | DIANTHUS THERAPEUTICS INC | 362K | $30M | 2.7% | −51% |
| 9 | ANNX | ANNEXON INC | 5.21M | $29M | 2.6% | −1% |
| 10 | KYTX | KYVERNA THERAPEUTICS INC | 3.11M | $27M | 2.4% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BAIN SIGNAL
AC read
Bain Capital Life Sciences Investors, LLC is a Other fund managing $1.5 billion in assets. The fund runs a focused portfolio of just 21 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed